About US
Contact us
-
Pfizer explores sale of hospital drugs unit amid activist investor's call for accountability: ReutersAfter a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to slim down by divesting its hospital drugs unit,Reuters reports, citing peop2024/11/15
-
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: LeerinkAs a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in acquiring external products with the potential to launch in the near term. Me2024/11/12
-
After election, FDA's Califf lays out hopes for his Trump-appointed successorWhile personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the qualities that he hopes his successor will have. “I think ability to funct2024/11/12
-
Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trialsLast month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward layoffs and scrap further development of its flagship seizure med. Now, M2024/11/6
-
Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 yearsFollowing an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based drugma2024/11/6
-
In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's DarzalexGSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win. The antibody-drug conjugate (ADC) has mount2024/10/30
-
Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJActivist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights. The invest2024/9/24
-
Takeda details another round of layoffs in Massachusetts as restructuring drive rolls onFollowing a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. Takeda is laying off dozens of employees in Massachusetts, according to a Worker Adjustment2024/9/24
-
ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discountAfter calling for a major discount for Pfizer’s popular transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis, a U.S. drug cost watchdog has provided a final analysis that includes a smaller—y2024/9/30
-
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit OpellaSanofi is now in“exclusive negotiations”with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella. With the French g2024/10/10